As Ingersoll (IR) Stock Declined, Holder Lansdowne Partners Uk Llp Lifted Its Holding; Incyte (INCY) Holder Renaissance Technologies Decreased Stake as Market Value Declined

Incyte Corporation (NASDAQ:INCY) Logo

Renaissance Technologies Llc decreased its stake in Incyte Corp (INCY) by 34.83% based on its latest 2018Q3 regulatory filing with the SEC. Renaissance Technologies Llc sold 320,600 shares as the company’s stock declined 4.36% with the market. The hedge fund held 600,000 shares of the commercial physical & biological resarch company at the end of 2018Q3, valued at $41.45 million, down from 920,600 at the end of the previous reported quarter. Renaissance Technologies Llc who had been investing in Incyte Corp for a number of months, seems to be less bullish one the $15.99B market cap company. The stock increased 1.93% or $1.42 during the last trading session, reaching $75.12. About 1.84M shares traded or 8.69% up from the average. Incyte Corporation (NASDAQ:INCY) has declined 31.01% since January 11, 2018 and is downtrending. It has underperformed by 31.01% the S&P500. Some Historical INCY News: 19/03/2018 – ASTRAZENECA – MEAN EGFR WAS DECREASED AT 24 WEEKS WITH DAPAGLIFLOZIN VS PLACEBO IN STUDY; 08/03/2018 – Report: Exploring Fundamental Drivers Behind Old Republic International, NiSource, MasTec, Lincoln National, Oceaneering Intern; 23/04/2018 – PANEL VOTES 5-10 AGAINST LILLY-INCYTE DRUG HIGH DOSE APPROVAL; 19/04/2018 – FDA STAFF – ADDITIONAL DATA LILLY PROVIDED IN RESUBMISSION OF RHEUMATOID ARTHRITIS DRUG DID NOT SUBSTANTIALLY ALTER EFFICACY AND SAFETY DATA IN ORIGINAL SUBMISSION; 09/04/2018 – MERCK & CO INC – SAFETY PROFILE OF KEYTRUDA IN PHASE 3 TRIAL WAS CONSISTENT; 10/04/2018 – Spectrum Pharmaceuticals Announces Update of MD Anderson’s Phase 2 Data Studying Poziotinib in EGFR Exon 20 Mutant Non-Small; 24/04/2018 – Immunovaccine and Incyte Expand Clinical Collaboration Evaluating Combination Immunotherapies in Advanced Recurrent Ovarian Can; 23/04/2018 – FDA PANEL VOTES 10-5 AGAINST SAFETY DATA ON BARICITINIB 4MG; 13/03/2018 – Incyte Corporation | Pemigatinib | N/A | 03/12/2018 | Treatment of cholangiocarcinoma | Designated | NFDA | N/A | | N/A; 06/04/2018 – Top 3 includes: #1 — added $BMY UPDATED: Keytruda/epacadostat combo crashes in PhIII melanoma study, raising questions about the future of IDO for Incyte $INCY $MRK

Lansdowne Partners Uk Llp increased its stake in Ingersoll (IR) by 432.14% based on its latest 2018Q3 regulatory filing with the SEC. Lansdowne Partners Uk Llp bought 324,687 shares as the company’s stock declined 4.65% with the market. The hedge fund held 399,821 shares of the o.e.m. company at the end of 2018Q3, valued at $40.90M, up from 75,134 at the end of the previous reported quarter. Lansdowne Partners Uk Llp who had been investing in Ingersoll for a number of months, seems to be bullish on the $23.40B market cap company. The stock increased 0.92% or $0.87 during the last trading session, reaching $95.27. About 1.05M shares traded. Ingersoll-Rand Plc (NYSE:IR) has risen 13.24% since January 11, 2018 and is uptrending. It has outperformed by 13.24% the S&P500. Some Historical IR News: 23/05/2018 – Ingersoll-Rand Presenting at UBS Conference Jun 14; 04/04/2018 – lngersoll Rand Declares Quarterly Dividend; 25/04/2018 – Ingersoll-Rand 1Q Rev $3.38B; 26/04/2018 – INGERSOLL-RAND PLC IR.N : CITIGROUP RAISES TARGET PRICE TO $111 FROM $109; 29/05/2018 – Thermo King “Moves Food” to Increase Food Security; 30/04/2018 – Ingersoll Rand Employees Worldwide Put Sustainability in Action with Earth Day Network’s Canopy Project; 25/04/2018 – INGERSOLL-RAND 1Q NET REV. $3.38B, EST. $3.19B; 04/04/2018 – Ingersoll Rand Declares Quarterly Dividend; 19/04/2018 – INGERSOLL-RAND ENTERS $1B SR UNSECURED REVOLVING CREDIT PACT; 25/04/2018 – INGERSOLL-RAND 1Q ADJ EPS CONT OPS 70C, EST. 62C

More notable recent Ingersoll-Rand Plc (NYSE:IR) news were published by: Seekingalpha.com which released: “Pivotal: Thoughts After A Conversation With The IR Director – Seeking Alpha” on October 18, 2018, also Seekingalpha.com with their article: “Banco Santander Deserves A Higher Valuation – Seeking Alpha” published on June 29, 2018, Seekingalpha.com published: “Ingersoll-Rand +4% as report cites takeover interest for power tools unit – Seeking Alpha” on October 25, 2018. More interesting news about Ingersoll-Rand Plc (NYSE:IR) were released by: Businesswire.com and their article: “Zayo to Host Second Quarter Fiscal Year 2019 Conference Call February 7, 2019 – Business Wire” published on January 10, 2019 as well as Fool.com‘s news article titled: “Why Johnson Controls International Declined Nearly 15% n December – Motley Fool” with publication date: January 09, 2019.

Among 25 analysts covering Ingersoll-Rand Plc (NYSE:IR), 17 have Buy rating, 0 Sell and 8 Hold. Therefore 68% are positive. Ingersoll-Rand Plc had 88 analyst reports since July 30, 2015 according to SRatingsIntel. The stock of Ingersoll-Rand Plc (NYSE:IR) earned “Buy” rating by Stifel Nicolaus on Wednesday, October 28. The stock of Ingersoll-Rand Plc (NYSE:IR) has “Buy” rating given on Monday, August 3 by Argus Research. The rating was maintained by Stifel Nicolaus on Tuesday, April 3 with “Buy”. The firm earned “Buy” rating on Tuesday, April 17 by BMO Capital Markets. On Wednesday, July 13 the stock rating was initiated by BMO Capital Markets with “Outperform”. Jefferies maintained the stock with “Buy” rating in Monday, September 11 report. The stock of Ingersoll-Rand Plc (NYSE:IR) has “Hold” rating given on Wednesday, January 3 by RBC Capital Markets. The stock of Ingersoll-Rand Plc (NYSE:IR) earned “Hold” rating by Susquehanna on Friday, January 12. UBS maintained Ingersoll-Rand Plc (NYSE:IR) rating on Thursday, August 30. UBS has “Buy” rating and $115 target. The company was maintained on Thursday, April 26 by Stifel Nicolaus.

Investors sentiment increased to 1.12 in Q3 2018. Its up 0.04, from 1.08 in 2018Q2. It is positive, as 29 investors sold IR shares while 208 reduced holdings. 98 funds opened positions while 168 raised stakes. 186.38 million shares or 2.72% less from 191.58 million shares in 2018Q2 were reported. Lombard Odier Asset Mngmt (Switzerland) Sa accumulated 0.05% or 4,644 shares. 8,425 were reported by Mai Mngmt. Bluemountain Capital Mgmt Ltd Liability invested in 26,423 shares. Sigma Planning has invested 0.04% in Ingersoll-Rand Plc (NYSE:IR). Commonwealth Bancorporation Of holds 0.03% or 34,150 shares in its portfolio. Ballentine Prtn Limited Liability Company has invested 0.01% in Ingersoll-Rand Plc (NYSE:IR). Prudential Fincl invested in 0.04% or 271,964 shares. Bokf Na holds 0.03% or 9,992 shares in its portfolio. 799,179 are owned by Thrivent Financial For Lutherans. Boyd Watterson Asset Ltd Llc Oh owns 4,983 shares. Cls Investments Ltd Liability holds 42 shares. Chevy Chase Tru Hldg Inc, a Maryland-based fund reported 202,781 shares. Amundi Pioneer Asset Management Inc has invested 0.24% in Ingersoll-Rand Plc (NYSE:IR). Toronto Dominion Bank accumulated 0.03% or 159,723 shares. Wetherby Asset Management Incorporated invested in 5,697 shares.

Lansdowne Partners Uk Llp, which manages about $30.64B and $9.48B US Long portfolio, decreased its stake in Spotify Technology S A by 138,542 shares to 1.03M shares, valued at $185.58M in 2018Q3, according to the filing. It also reduced its holding in Jpmorgan Chase & Co (NYSE:JPM) by 4.85 million shares in the quarter, leaving it with 8.01 million shares, and cut its stake in Bank Amer Corp (NYSE:BAC).

More notable recent Incyte Corporation (NASDAQ:INCY) news were published by: Streetinsider.com which released: “Incyte (INCY) Reports First Patient Treated in Phase 3 Clinical Trial Program for Ruxolitinib Cream in Atopic Dermatitis – StreetInsider.com” on December 20, 2018, also Seekingalpha.com with their article: “Incyte Should Break Out Of Doldrums – Seeking Alpha” published on August 28, 2018, Seekingalpha.com published: “Incyte Scores Lucrative Deal For Its 3 Pipeline Products – Seeking Alpha” on December 26, 2018. More interesting news about Incyte Corporation (NASDAQ:INCY) were released by: Seekingalpha.com and their article: “Incyte: Getting More Excited – Seeking Alpha” published on August 02, 2018 as well as Nasdaq.com‘s news article titled: “S&P 500 Movers: LNT, CELG – Nasdaq” with publication date: January 03, 2019.

Renaissance Technologies Llc, which manages about $63.99 billion and $97.27B US Long portfolio, upped its stake in Forrester Resh Inc (NASDAQ:FORR) by 54,100 shares to 751,900 shares, valued at $34.51 million in 2018Q3, according to the filing. It also increased its holding in Bancorp Inc Del (NASDAQ:TBBK) by 346,200 shares in the quarter, for a total of 537,400 shares, and has risen its stake in Bce Inc (NYSE:BCE).

Among 30 analysts covering Incyte (NASDAQ:INCY), 21 have Buy rating, 0 Sell and 9 Hold. Therefore 70% are positive. Incyte had 104 analyst reports since August 6, 2015 according to SRatingsIntel. Barclays Capital maintained it with “Overweight” rating and $85 target in Friday, February 12 report. The firm has “Overweight” rating by Barclays Capital given on Wednesday, August 2. The firm has “Buy” rating given on Thursday, August 31 by J.P. Morgan. The firm earned “Buy” rating on Sunday, June 4 by Cowen & Co. As per Wednesday, July 13, the company rating was initiated by RBC Capital Markets. The rating was maintained by UBS with “Buy” on Wednesday, August 5. The firm has “Overweight” rating by JP Morgan given on Monday, April 9. BMO Capital Markets maintained the shares of INCY in report on Tuesday, January 2 with “Buy” rating. The company was maintained on Thursday, October 26 by BMO Capital Markets. The stock has “Buy” rating by Raymond James on Monday, September 11.

Since August 21, 2018, it had 1 insider purchase, and 8 insider sales for $6.37 million activity. Shares for $70,000 were sold by Flannelly Barry P on Wednesday, October 3. BIENAIME JEAN JACQUES bought $68,765 worth of stock or 1,000 shares. 10,000 shares were sold by Trower Paul, worth $700,000 on Wednesday, October 3. Wenqing Yao sold $750,000 worth of Incyte Corporation (NASDAQ:INCY) on Friday, January 4.

Incyte Corporation (NASDAQ:INCY) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.